Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Garnero

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Drugs|November 23, 2006
Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfallsSerge Cremers, Patrick Garnero
Current Opinion in Rheumatology|September 10, 2003
Biomarkers in osteoarthritisPatrick Garnero, Pierre D Delmas
Current Opinion in Rheumatology|June 18, 2004
Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkersPatrick Garnero, Pierre D Delmas
Arthritis and Rheumatism|April 9, 2005
Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritisNadine Charni, Fabrice Juillet, Patrick Garnero
Current Rheumatology Reports|April 18, 2007
Monitoring cartilage turnoverNadine Charni-Ben Tabassi, Patrick Garnero
Molecular and Cellular Endocrinology|January 2, 2016
Periostin action in boneNicolas Bonnet, Patrick Garnero, Serge Ferrari
Clinical Chemistry|November 14, 2007
Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosisPatrick Garnero, Philippe Vergnaud, Nicholas Hoyle
Therapeutic Advances in Musculoskeletal Disease|October 7, 2021
Soluble biological markers in osteoarthritisJean-Charles Rousseau, Roland Chapurlat, Patrick Garnero
Rheumatology (Oxford, England)|February 4, 2020
The role of biochemical markers of joint tissue remodelling to predict progression and treatment efficacy in inflammatory rheumatic diseasesPatrick Garnero, Robert Landewé, Roland D Chapurlat
Calcified Tissue International|July 21, 2017
Development of a New Immunoassay for Human Cathepsin K-Generated Periostin Fragments as a Serum Biomarker for Cortical BonePatrick Garnero, Nicolas Bonnet, Serge L Ferrari
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Drugs|November 23, 2006
Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfallsSerge Cremers, Patrick Garnero
Current Opinion in Rheumatology|September 10, 2003
Biomarkers in osteoarthritisPatrick Garnero, Pierre D Delmas
Current Opinion in Rheumatology|June 18, 2004
Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkersPatrick Garnero, Pierre D Delmas
Arthritis and Rheumatism|April 9, 2005
Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritisNadine Charni, Fabrice Juillet, Patrick Garnero
Current Rheumatology Reports|April 18, 2007
Monitoring cartilage turnoverNadine Charni-Ben Tabassi, Patrick Garnero
Molecular and Cellular Endocrinology|January 2, 2016
Periostin action in boneNicolas Bonnet, Patrick Garnero, Serge Ferrari
Clinical Chemistry|November 14, 2007
Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosisPatrick Garnero, Philippe Vergnaud, Nicholas Hoyle
Therapeutic Advances in Musculoskeletal Disease|October 7, 2021
Soluble biological markers in osteoarthritisJean-Charles Rousseau, Roland Chapurlat, Patrick Garnero
Rheumatology (Oxford, England)|February 4, 2020
The role of biochemical markers of joint tissue remodelling to predict progression and treatment efficacy in inflammatory rheumatic diseasesPatrick Garnero, Robert Landewé, Roland D Chapurlat
Calcified Tissue International|July 21, 2017
Development of a New Immunoassay for Human Cathepsin K-Generated Periostin Fragments as a Serum Biomarker for Cortical BonePatrick Garnero, Nicolas Bonnet, Serge L Ferrari
Pageof 12